These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
353 related articles for article (PubMed ID: 36457261)
1. SARS-CoV-2 Infection and Liver Disease: A Review of Pathogenesis and Outcomes. Baldelli L; Marjot T; Barnes E; Barritt AS; Webb GJ; Moon AM Gut Liver; 2023 Jan; 17(1):12-23. PubMed ID: 36457261 [TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 infection in patients with a normal or abnormal liver. Cabibbo G; Rizzo GEM; Stornello C; Craxì A J Viral Hepat; 2021 Jan; 28(1):4-11. PubMed ID: 33190321 [TBL] [Abstract][Full Text] [Related]
3. COVID-19 and the liver: A 2021 update. Spearman CW; Aghemo A; Valenti L; Sonderup MW Liver Int; 2021 Sep; 41(9):1988-1998. PubMed ID: 34152690 [TBL] [Abstract][Full Text] [Related]
4. COVID-19 and liver disease: mechanistic and clinical perspectives. Marjot T; Webb GJ; Barritt AS; Moon AM; Stamataki Z; Wong VW; Barnes E Nat Rev Gastroenterol Hepatol; 2021 May; 18(5):348-364. PubMed ID: 33692570 [TBL] [Abstract][Full Text] [Related]
5. Modifications of Medical Care of Chronic Liver Diseases During COVID-19 Pandemic: Necessity or Novelty? Soliman HH; Emara MH; Elkadeem M; Abd-Elsalam S Infect Disord Drug Targets; 2021; 21(8):e160921189886. PubMed ID: 33397247 [TBL] [Abstract][Full Text] [Related]
6. Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination. Nevola R; Criscuolo L; Beccia D; Delle Femine A; Ruocco R; Imbriani S; Alfano M; Villani A; Russo A; Perillo P; Marfella R; Adinolfi LE; Sasso FC; Marrone A; Rinaldi L World J Gastroenterol; 2023 Feb; 29(5):800-814. PubMed ID: 36816617 [TBL] [Abstract][Full Text] [Related]
8. Management of COVID-19 patients with chronic liver diseases and liver transplants. Hu X; Sun L; Guo Z; Wu C; Yu X; Li J Ann Hepatol; 2022; 27(1):100653. PubMed ID: 34929350 [TBL] [Abstract][Full Text] [Related]
9. COVID-19 and the Liver: Lessons Learnt from the EAST and the WEST, A Year Later. Ekpanyapong S; Bunchorntavakul C; Reddy KR J Viral Hepat; 2022 Jan; 29(1):4-20. PubMed ID: 34352133 [TBL] [Abstract][Full Text] [Related]
10. Progressive cholestasis and associated sclerosing cholangitis are frequent complications of COVID-19 in patients with chronic liver disease. Hartl L; Haslinger K; Angerer M; Semmler G; Schneeweiss-Gleixner M; Jachs M; Simbrunner B; Bauer DJM; Eigenbauer E; Strassl R; Breuer M; Kimberger O; Laxar D; Lampichler K; Halilbasic E; Stättermayer AF; Ba-Ssalamah A; Mandorfer M; Scheiner B; Reiberger T; Trauner M Hepatology; 2022 Dec; 76(6):1563-1575. PubMed ID: 35596929 [TBL] [Abstract][Full Text] [Related]
14. Mortality Trends in Chronic Liver Disease and Cirrhosis in the United States, Before and During COVID-19 Pandemic. Kim D; Bonham CA; Konyn P; Cholankeril G; Ahmed A Clin Gastroenterol Hepatol; 2021 Dec; 19(12):2664-2666.e2. PubMed ID: 34256143 [TBL] [Abstract][Full Text] [Related]
15. Risk of New-Onset Liver Injuries Due to COVID-19 in Preexisting Hepatic Conditions-Review of the Literature. Bucurica S; Ionita Radu F; Bucurica A; Socol C; Prodan I; Tudor I; Sirbu CA; Plesa FC; Jinga M Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676691 [TBL] [Abstract][Full Text] [Related]
16. Liver disease and outcomes among COVID-19 hospitalized patients - A systematic review and meta-analysis. Sharma A; Jaiswal P; Kerakhan Y; Saravanan L; Murtaza Z; Zergham A; Honganur NS; Akbar A; Deol A; Francis B; Patel S; Mehta D; Jaiswal R; Singh J; Patel U; Malik P Ann Hepatol; 2021; 21():100273. PubMed ID: 33075578 [TBL] [Abstract][Full Text] [Related]
17. Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study). Sarin SK; Choudhury A; Lau GK; Zheng MH; Ji D; Abd-Elsalam S; Hwang J; Qi X; Cua IH; Suh JI; Park JG; Putcharoen O; Kaewdech A; Piratvisuth T; Treeprasertsuk S; Park S; Wejnaruemarn S; Payawal DA; Baatarkhuu O; Ahn SH; Yeo CD; Alonzo UR; Chinbayar T; Loho IM; Yokosuka O; Jafri W; Tan S; Soo LI; Tanwandee T; Gani R; Anand L; Esmail ES; Khalaf M; Alam S; Lin CY; Chuang WL; Soin AS; Garg HK; Kalista K; Batsukh B; Purnomo HD; Dara VP; Rathi P; Al Mahtab M; Shukla A; Sharma MK; Omata M; Hepatol Int; 2020 Sep; 14(5):690-700. PubMed ID: 32623632 [TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 and the liver: clinical and immunological features in chronic liver disease. Luxenburger H; Thimme R Gut; 2023 Sep; 72(9):1783-1794. PubMed ID: 37316169 [TBL] [Abstract][Full Text] [Related]
19. Risk of mortality in people with chronic liver diseases hospitalized for Coronavirus disease of 2019 (COVID-19) in a tertiary hospital in Lombardy, Italy. Ranzenigo M; Ceccarelli D; Galli L; Bertoni C; Siribelli A; Messina E; Hasson H; Lolatto R; Castagna A; Uberti-Foppa C; Morsica G New Microbiol; 2023 Sep; 46(3):296-302. PubMed ID: 37747475 [TBL] [Abstract][Full Text] [Related]